Blog
RSS FeedPosted by Michael Wonder on 03 Aug 2024
Novo Nordisk latest drugmaker to face setback in IRA litigation
1 August 2024 - A federal court backed the Biden administration’s Medicare drug price negotiation program on Wednesday, the latest ...
Posted by Michael Wonder on 29 Jul 2024
Luye Pharma announces US FDA approval of Erzofri (paliperidone palmitate) extended release injectable suspension for treating schizophrenia and schizoaffective disorder
28 July 2024 - Luye Pharma today announced that the US FDA has approved the company's Erzofri (paliperidone palmitate) extended-release injectable ...
Posted by Michael Wonder on 19 Jul 2024
Johnson & Johnson, BMS fight US drug price plan at Third Circuit
16 July 2024 - Pharmaceutical giants Johnson & Johnson, BMS and AstraZeneca are rejecting federal district court decisions that rule ...
Posted by Michael Wonder on 17 Jul 2024
The Biden-Harris Administration releases final Part Two guidance to help people with Medicare prescription drug coverage manage prescription drug costs
16 July 2024 - The Department of Health and Human Services, through the Centers for Medicare & Medicaid Services (CMS), continues ...
Posted by Michael Wonder on 09 Jul 2024
Insurers pocketed $50 billion from Medicare for diseases no doctor treated
8 July 2024 - Questionable diagnoses of HIV and other maladies triggered extra Medicare Advantage payments; ‘It’s anatomically impossible’. ...
Posted by Michael Wonder on 03 Jul 2024
Formulary coverage of brand name adalimumab and biosimilars across Medicare Part D plans
2 July 2024 - Adalimumab (Humira) is a top-selling drug in Medicare Part D, representing $4.7 billion of Medicare spending in ...
Posted by Michael Wonder on 03 Jul 2024
Approval of newest Alzheimer’s drug will accelerate new era of treatment
2 July 2024 - With the arrival of Lilly’s Kisunla, Alzheimer’s care could become more like treatment of cancer and rheumatoid ...
Posted by Michael Wonder on 13 May 2024
First ever life-saving treatment for rare heart condition available on the NHS
13 May 2024 - NHS patients with a life-threatening heart condition are set to benefit from a cutting-edge new medicine ...
Posted by Michael Wonder on 19 Apr 2024
Medicare official says breakthrough device reimbursement rule coming in early summer
19 April 2024 - A federal rule aiming to make reimbursement for breakthrough devices easier is slated for early summer, ...
Posted by Michael Wonder on 12 Apr 2024
Medicare drug price negotiations: policy implications of the first 10 drugs’ features
9 April 2024 - This article describes how CMS’s approach to implementing the negotiations will be shaped by the distinctive ...
Posted by Michael Wonder on 21 Mar 2024
Medicare opens door for covering obesity drugs
21 March 2024 - The agency says health plans may pay for the drugs if used to prevent heart attacks and ...
Posted by Michael Wonder on 20 Mar 2024
New treatment for essential tremor now available through Medicare
19 March 2024 - Australians living with essential tremor can now access magnetic resonance-guided focused ultrasound through Medicare, with the ...
Posted by Michael Wonder on 07 Mar 2024
Biden says Medicare should negotiate prices for at least 50 drugs each year, up from a target of 20
6 March 2024 - That proposal is one of several new health care policy plans Biden will outline during his State ...
Posted by Michael Wonder on 29 Feb 2024
House looks to weaken Medicare negotiation
29 February 2024 - Two proposals to weaken Medicare’s drug price negotiation program are getting a hearing before a House Energy ...
Posted by Michael Wonder on 13 Feb 2024
Federal judge tosses PhRMA lawsuit challenging Medicare drug negotiations
12 February 2024 - A Texas federal judge on Monday dismissed a lawsuit challenging the Biden administration’s Medicare drug price ...